Cargando…
Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization
Colorectal cancer (CRC) remains a leading cause of cancer death, and its mortality is associated with metastasis and chemoresistance. We demonstrate that oxaliplatin-resistant CRC cells are sensitized to TRAIL-mediated apoptosis. Oxaliplatin-resistant cells exhibited transcriptional downregulation o...
Autores principales: | Greenlee, Joshua D, Lopez-Cavestany, Maria, Ortiz-Otero, Nerymar, Liu, Kevin, Subramanian, Tejas, Cagir, Burt, King, Michael R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331188/ https://www.ncbi.nlm.nih.gov/pubmed/34342264 http://dx.doi.org/10.7554/eLife.67750 |
Ejemplares similares
-
Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
por: Grayson, Korie A., et al.
Publicado: (2021) -
Platelet mediated TRAIL delivery for efficiently targeting circulating tumor cells
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2020) -
TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2021) -
Piezo1 Mechano-Activation Is Augmented by Resveratrol and Differs between Colorectal Cancer Cells of Primary and Metastatic Origin
por: Greenlee, Joshua D., et al.
Publicado: (2022) -
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer
por: Arai, Hiroyuki, et al.
Publicado: (2020)